文献速递妇科产科

宫腔镜旋切术用于子宫内膜癌诊断是否增加风险?

Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?
PubMed 文献 · J Minim Invasive Gynecol · 2021-02-08

本研究回顾性分析2013-2018年289例子宫内膜癌患者,比较宫腔镜旋切术与其他活检方式对腹膜细胞学阳性、淋巴血管间隙浸润及手术升级的影响。结果显示旋切术未增加恶性细胞播散、淋巴血管间隙浸润或分期升级,在低级别和高级别内膜癌中均安全。

要点

  • 宫腔镜旋切术不增加腹膜细胞学阳性率。
  • 旋切术未增加淋巴血管间隙浸润或手术分期升级。
  • 低级别和高级别内膜癌中旋切术均安全。

核心结论

  • 宫腔镜旋切术是低级别和高级别子宫内膜病理的安全诊断方法,不增加恶性细胞播散、淋巴血管间隙浸润或分期升级。

研究设计与样本

  • 回顾性病历审查,纳入2013-2018年Karmanos癌症研究所289例子宫内膜癌患者,排除外院活检、活检前已知IV期及活检方式或组织学缺失者。

主要发现

  • 53例(18%)接受宫腔镜旋切术,替代活检方式包括宫腔镜无旋切81例(28%)、内膜活检112例(38.7%)及诊刮43例(15%)。
  • 腹膜细胞学阳性34例(12%),阴性165例(57%),未行细胞学检查90例(31%)。
  • 按组织学亚型比较,低级别和高级别中腹膜细胞学(p=.704和.727)、分期(p=.773和.053)及淋巴血管间隙浸润(p=.400和.142)均无差异。

临床怎么用

  • 对于需宫腔镜诊断的子宫内膜癌患者,旋切术不增加腹膜播散或分期升级风险,可作为安全诊断选项。

局限性

  • 回顾性设计,样本来自单一中心,部分患者未行腹膜细胞学检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Operative hysteroscopy requires elevated intrauterine pressures, which could lead to the spread of malignant cells into the peritoneal cavity. Currently, there is a paucity of data analyzing clinical outcomes in endometrial cancer after hysteroscopic morcellation with newer equipment. In this study, we sought to determine whether there are increased rates of positive peritoneal cytology, lymphovascular space invasion, or surgical upstaging in patients undergoing hysteroscopic morcellation compared with alternative endometrial biopsy methods. DESIGN: A retrospective chart review of patients from 2013-2018 was performed. The exclusion criteria included biopsy at outside institution, stage IV endometrial cancer known before biopsy, and missing data regarding biopsy method and histology. Peritoneal cytology results, lymphovascular space invasion, and surgical staging were compared by method of biopsy and histology using chi-square and Kruskal-Wallis tests. SETTING: The patients included in this study were accrued from the Karmanos Cancer Insittute in Detroit, Michigan. PATIENTS: A total of 289 patients met the inclusion criteria: 184 patients were classified as low-grade (Fédération Internationale de Gynécologie et d'Obstétrique grades 1 and 2) and 105 as high-grade (Fédération Internationale de Gynécologie et d'Obstétrique grade 3, serous, clear cell, and carcinosarcoma) endometrial cancer. INTERVENTIONS: Fifty-three patients (18%) underwent hysteroscopy with morcellation. Alternative biopsy methods included hysteroscopy without morcellation, n = 81 (28%); endometrial biopsy, n = 112 (38.7%); and dilation and curettage, n = 43 (15%). MEASUREMENTS AND MAIN RESULTS: Positive peritoneal cytology was noted in 34 cases (12%) and negative cytology in 165 (57%). Cytology was not performed in 90 cases (31%). When comparing outcomes by histologic subtypes, no difference was seen in peritoneal cytology (p = .704 and .727 for low grade and high grade, respectively), stage (p = .773 and .053 for low grade and high grade, respectively) or lymphovascular space invasion (p = .400 and .142 for low grade and high grade, respectively). CONCLUSION: Our study demonstrates that hysteroscopy with morcellation is a safe diagnostic method for low- and high-grade endometrial pathologic conditions and does not lead to increased dissemination of malignant cells, lymphovascular space invasion, or upstaging of patients.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Kelly RA, Contos GT, Walker CA, et al. Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk? J Minim Invasive Gynecol. 2021. PMID: 33571678. doi:10.1016/j.jmig.2021.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。